Two University of Arizona researchers are co-authors of a report released that examines current statistics of cardiac arrest in the United States and recommends public health strategies to improve survival rates.
The U.S. Centers for Disease Control and Prevention reports that 1 in every 150 children is born with congenital CMV. The U.S. Senate has designated the month of June as "National Cytomegalovirus Awareness Month."
Taylor S. Riall, MD, PhD, a surgical oncologist specializing in pancreaticobiliary disease (complex disorders of the pancreas and bile ducts) has been named chief of the Division of General Surgery/Surgical Oncology in the University of Arizona Department of Surgery.
Researchers at the University of Arizona College of Pharmacy have discovered that nonalcoholic steatohepatitis (NASH), an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.
As executive director of INC, Dr. Bedrick is responsible for the overall strategic planning and management of collaborative research endeavors among academic neonatologists, industry clinical staff and regulatory agency staff that will accelerate an understanding of medicine use in neonates.
To address the critical lack of diversity in the health-care workforce in Arizona and the nation, the Arizona Health Sciences Center, with programs in Tucson and Phoenix, is working to recruit, educate and train tomorrow’s health-care leaders.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
The University of Arizona Department of Pediatrics and Banner Children’s – Diamond Children’s Medical Center welcome new faculty member Geetha Gopalakrishnan, MD, assistant professor, to the Division of Hospital Medicine.